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Abstract: Sulfated fucans comprise families of polydisperse natural polysaccharides  
based on sulfated L-fucose. Our aim was to investigate whether fucan nanogel induces  
cell-specific responses. To that end, a non toxic fucan extracted from Spatoglossum schröederi 
was chemically modified by grafting hexadecylamine to the polymer hydrophilic backbone. 
The resulting modified material (SNFuc) formed nanosized particles. The degree of 
substitution with hydrophobic chains was close to 100%, as estimated by elemental analysis. 
SNFfuc in aqueous media had a mean diameter of 123 nm and zeta potential of  
−38.3 ± 0.74 mV, as measured by dynamic light scattering. Nanoparticles conserved their 
size for up to 70 days. SNFuc cytotoxicity was determined using the MTT assay after 
culturing different cell lines for 24 h. Tumor-cell (HepG2, 786, H-S5) proliferation was 
inhibited by 2.0%–43.7% at nanogel concentrations of 0.05–0.5 mg/mL and rabbit aorta 
endothelial cells (RAEC) non-tumor cell line proliferation displayed inhibition of  
8.0%–22.0%. On the other hand, nanogel improved Chinese hamster ovary (CHO) and 
monocyte macrophage cell (RAW) non-tumor cell line proliferation in the same 
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concentration range. The antiproliferative effect against tumor cells was also confirmed 
using the BrdU test. Flow cytometric analysis revealed that the fucan nanogel inhibited 
786 cell proliferation through caspase and caspase-independent mechanisms. In addition, 
SNFuc blocks 786 cell passages in the S and G2-M phases of the cell cycle.  
Keywords: nanogels; cancer cells; sulfated polysaccharides; Spatoglossum schröederi 
 
1. Introduction 
Nanoparticles have attracted significant attention due to their various applications in the fields  
of biotechnology and biomedical sciences. The term nanogel is frequently used to define aqueous 
dispersions of hydrogel particles composed of nanoscale-sized physically or chemically cross-linked 
polymer networks [1]. Their application in medicine is very promising since they exhibit high stability 
and loading capacity, as well as responsiveness to environmental factors such as pH, ionic strength  
and temperature, making them viable candidates for transport and drug release. However, when 
nanoparticles enter the bloodstream they are often opsonized by plasma proteins and/or rapidly 
removed from the blood by the mononuclear phagocytic system [2]. Hydrophobic particles are 
typically opsonized much faster than their hydrophilic counterparts [3]. Several researchers have 
focused on the camouflaging or masking of nanoparticle surfaces to avoid these events. As a result, 
some polymers have been evaluated as protecting groups, including polyacrylamides, polyvinyl 
alcohol (PVA), poly(ethylene glycol) (PEG) and polysaccharides [4].  
Recently, self-assembled nanoparticles based on natural polysaccharides have been of particular 
interest in light of their good biocompatibility, biodegradability, reduced toxic side effects and 
improved therapeutic effects [5]. Another advantage of using polysaccharides is that these molecules 
contain reactive groups which can be used to introduce different chemical ligands [6]. For example, 
polysaccharides can be used to synthesize water-soluble polymers with grafted hydrophobic molecules, 
that is, amphiphile polymers [7]. Through self-assembly, hydrophobic regions are directed from 
outside the molecule to form an inner core surrounded by hydrophilic chains. This type of structure is 
suitable for trapping hydrophobic substances such as hydrophobic drugs [8]. 
Recently, Bae and colleagues [9] reported that heparin nanogels were able to induce apoptosis in 
tumor cells. The authors attributed antitumor activity to heparin, a sulfated polysaccharide exhibiting 
several biological activities. Of these, the most noteworthy and widely studied is anticoagulant  
activity [10]. Pharmaceutical-grade heparin is derived from porcine intestinal mucosa through several 
steps of purification. However, the amount of heparin obtained from each animal is small and may be 
accompanied by impurities, including other sulfated polysaccharides and proteins [11]. Sulfated 
polysaccharides from seaweed, such as sulfated fucans, are an alternative to heparin.  
Synthesis of nanoparticles from fucans is still new and to the best of our knowledge only one article 
exists describing this process [12]. Sulfated fucans comprise families of polydisperse polysaccharides 
based on sulfated L-fucose. Heterofucans are also known as fucoidans and are not widespread in 
nature, occurring only in brown seaweed and tunicates [13,14], with seaweeds being the most 
important source of fucans. Seaweed synthesizes fucan and displays unique structural characteristics 
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reflected in the biological, pharmacological and biotechnological properties of the polysaccharide. 
Furthermore, these structural characteristics can be modified by biotic and abiotic factors that seaweed 
is exposed to, as well as extraction and purification methods used to obtain sulfated polysaccharides. 
Recent reviews regarding seaweed fucans have been restricted to their structural characteristics and 
primary biological/pharmacological activities [15]. 
The brown seaweed Spatoglossum schröederi synthesizes three heterofucans, namely fucan A, 
fucan B and fucan C. Our group proposes 21 kDa fucan A structure as consisting of a core of β(1–3) 
glucuronic acid-containing 4.5 kDa oligosaccharide, with branches at C-4 of α(1–3)-linked fucose 
chains. Fucose is substituted at C-4 and C-2 (minor) with sulfate groups. In addition, some fucose 
residues are substituted at C-2 with chains of β(1–4) xylose, which, in turn, is also partially sulfated 
(Figure 1) [16]. This fucan displayed no mutagenicity or genotoxicity [17]. In addition, fucan A shows 
no toxicity in vivo [18]. Thus, in the present study we synthesized and characterized hydrophobically 
modified fucan A nanogel (SNFuc), assessing their effect on several tumor and normal cell lines.  
Figure 1. Structure of fucan A from Spatoglossum schroederi proposed by Leite and 
colleagues [16]. 
 
2. Results and Discussion 
2.1. FT-IR Analysis  
The FI-IR analysis of native fucan and SNFuc is showed in Figure 2. Characteristic sulfate 
absorptions were identified in the FT-IR spectra of compounds: bands around 1274 cm
−1
 for 
asymmetric S=O stretching vibration and bands around 1045 cm
−1
 for symmetric C–O vibration 
associated with a C–O–SO3 group. The peaks at 810–850 were caused by the bending vibration of  
C–O–S [19]. At 3000–3400 cm−1 Fuc A and SNFuc showed bands from the stretching vibration of  
O–H and C–H, respectively [20]. However, the SNFuc FI-IR spectrum showed the intensity of these 
bands increased due the presence of N–H (3000–3400 cm−1) and stretching vibrations of CH2 in 
hexadecyl residues (2921 and around 2850 cm
−1
) [21]. The peak of the C–H symmetric deformation 
vibration was at 1427 cm
−1
 [22]. The intensities of this absorption band increased with chain length of 
the CH2 groups in SNFuc. A band at 1616 cm
−1
 was identified only in fucan A spectrum and was 
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assigned to antisymmetric stretching vibration of COO
−
 of glucuronic acid [23]. The presence 
glucuronic acid was also confirmed with a symmetric vibration peak around 1410 cm
−1
. On the other 
hand, SNFuc spectrum showed a band at 1740 cm
−1
 caused by C=O stretch vibrations in COOH and 
esters [24]. The band at1643 cm
−1
 was due the amine I vibration which is overlapped with the vibration 
of water. Less intense peak around1550 cm
−1
 arose from amide II vibration in alkylamides and thus 
confirmed amidation. Additionally, band at 620 cm
−1
 was assigned to N–C=O bending vibration [24].  
Figure 2. FTIR spectra of native fucan and SNFuc. 
 
2.2. 
1
H NMR and Elemental Analysis 
The native fucan A 
1
H NMR spectrum is shown in Figure 3A. The two main α-anomeric protons, 
which correspond to α-L-fucose units, were observed at 5.18 and 5.08 ppm. In contrast with the 
simplicity of both α-fucose residues, β systems show a certain degree of multiplicity, likely due to 
diversity in the positions of interglycosidic linkages of sugar residues. β-Anomeric protons appeared as 
two unresolved multiplets centered at 4.4 and 4.9 ppm, together with signals of protons from sulfation 
sites, whereas the remaining fucan A protons appear in the range of 3.5–4.5 ppm [16]. Signals around 
1.2–1.4 ppm were assigned to CH3 protons of fucose residues. 
Figure 2B depicts the 
1
H NMR of SNFuc. The reaction between fucan and hexadecylamine follows 
a Michael addition mechanism. Signals between 5.6 and 1.0 ppm in the 
1
H NMR spectrum of SNFuc 
are assigned to protons from the fucan A scaffold. Proton peaks from hexadecylamine are observed  
Mar. Drugs 2012, 10 2006 
 
 
at 2 ppm and at 1.0–1.3 ppm. These overlap the signals of CH3 groups from fucose residues  
(Figure 3B) [25]. The proton signal near 3 ppm is attributive to neither the fucan nor the 
hexadeyilamine and thus it seems to arise from a contaminant that could not be eliminated by 
extensive 2 dialyses. According to COSY experiment (Figure 3C), this signal does not correlated with 
those of polysaccharide or substituent.  
Figure 3. 
1
H NMR spectra of native fucan (A) and SNFuc in D2O at 25 °C (B) and 
Correlation Spectroscoy analysis (COSY spectrum) of SNFuc (C). 
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Figure 3. Cont. 
 
Due to the overlap of the peaks arising from the fucan and the hexadecylamine protons, it was  
not possible to determine the degree of substitution (DS) using the 
1
H NMR spectrum analysis. 
Nonetheless the 
1
H NMR spectrum confirms the chemical grafting of hexadecylamine molecule to the 
fucan structure, as evidenced by the hexadecylamine peaks. 
Therefore the degree of substitution (DS) was estimated through the SNFuc elemental analysis, 
based on the ratio of amide nitrogen and the sulfate sulfur from the fucans. This resulted in a N/S ratio 
of 0.66 (2.9/4.4). Taking into account the proposed structure of the fucan and the corresponding 
theoretical elemental composition, a degree of substitution superior to 100% is obtained. Indeed, 
according to the structure shown in Figure 1, fucan has 14 sulfate groups per 6 carboxylic groups. 
Thus, if 100% of the carboxylic groups react with an hexadecylamine, we would end up with a ratio of 
6N/14S, therefore our experimental N/S ratio corresponds to a degree of substitution above the 
maximum theoretical value. This may be interpreted as significant of a very high degree of substitution, 
probably close to 100%, the value obtained being certainly overestimated due to heterogeneity of the 
fucan; the theoretical structure used in this estimation may not accurately correspond to the material used. 
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2.3. Formation of Nanoparticles 
Dissolution of SNFuc in water is expected to give rise to micelle formation, owing to the amphiphilic 
nature of the molecule. Nanogel formation was assessed by Dynamic Light Scattering (DLS). 
DLS analysis provides valuable information on the homogeneity of dispersion. SNFuc (0.1 g/dL) in 
aqueous media had a mean diameter of 123 nm, with unimodal size distribution and a corresponding 
average polydispersity index of 0.269 (Figure 4A). Since size distribution intensity is somewhat 
influenced by the presence of larger particles, whereas volume distribution better characterizes the 
more representative population, we also analyzed the volume distribution of nanoparticles. SNFuc 
volume analysis also demonstrated the homogeneity of nanoparticles (Figure 4B). The observation of 
the nanogel by CryoSEM provides images of particles in the same size range as detected by  
DLS (Figure 4D). 
Figure 4. Particle size distribution (A) and volume (%) (B) of SNFuc nanogels (0.1 g/dL) 
measured by dynamic light scattering (DLS) and Fucan nanogels observed by Cryo-SEM (C). 
The figures represent data obtained from the determination of fucan nanoparticle properties 
prepared in three different experiments; (D) Colloidal stability of nanoparticles in water. 
The SNFuc solution (0.1 g/dL) was stored at 25 °C for up to 70 days. The error bar 
represents standard deviation (n = 5). 
 
(A) 
 
(B) 
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Figure 4. Cont. 
 
(C) 
 
(D) 
2.4. Nanogel Stability 
Present and future nanogel applications require a high degree of control over properties, among 
which, particle stability in aqueous solutions is one of the most sought after since this would facilitate 
its biomedical application. Analysis of nanoparticle stability in a time interval allows us to determine 
whether molecule characteristics are ideal for biomedical applications [26,27]. 
The magnitude of zeta potential gives an indication of colloidal system stability. Particles in a 
suspension with a large zeta potential value, whether negative or positive, will repel each other and  
as such do not aggregate. However, if the particles exhibit low zeta potential value (close to zero), 
there is no electrostatic force to prevent particles from aggregating. Nanogel has a zeta potential of 
−38.3 ± 0.74 mV and is therefore expected to be stable in aqueous suspension [28]. 
Assessing changes in nanoparticle size over a period of time is a good indicator of its stability. Thus, 
in order to evaluate the stability of SNFuc nanoparticles, we established their size by DLS, at 25 °C, 
for up to 70 days (Figure 4C). Data showed indicated high colloidal stability of nanoparticles in an 
aqueous medium. 
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2.5. Effect of SNFuc on Cell Proliferation 
Antiproliferative activity of SNFuc on CHO, RAW, 786, HepG2, RAEC and HS-5 cells was 
investigated using the colorimetric MTT assay. Proliferation of non-tumor cells CHO and RAW 
(Figure 4A,B) was stimulated by the presence of SNFuc, after an incubation period of 24 h. On the 
other hand, SNFuc showed antiproliferative activity when RAEC cells and tumor cells were used 
(Figure 5). Additionally, our data suggest that cytotoxicity of fucan nanogel was cell-specific, arising 
from cell-fucan nanogel interaction. In Figure 6 the SNFuc antiproliferative activity against 786, HepG2 
and HS-5 cells was further confirmed using BrdU incorporation as described in the Experimental 
Section. Proliferation of the 786 tumor cell was the most affected one, showing an inhibition rate of 
approximately 40% in the presence of SNFuc. This cell line was therefore used in additional tests. 
Figure 5. Effect of SNFuc nanogel on Chinese hamster ovary (CHO) (A); mouse monocyte 
macrophage (RAW) (B); human renal cell carcinoma (786) (C); human hepatocellular 
carcinoma (HepG2) (D); rabbit aorta endothelial cells (RAEC) (E) and human marrow stromal 
cell line (HS-5) (F) cell proliferation, after 24 h of incubation in different concentrations 
(50, 100 and 500 µg/mL). Results are expressed as percentage of control cells normalized 
to 100% in the absence of polysaccharide (mean ± SD of seven determinations). Different 
letters indicate a significant difference between concentrations of individual sulfated 
polysaccharides (p < 0.05). 
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Figure 6. Effect of SNFuc on tumor cells proliferation. The rate of cell proliferation 
inhibition was determined using BrdU. Results are expressed as percentage of control cells 
normalized to 100% in the absence of polysaccharide (mean ± SD of four determinations). 
Different letters indicate a significant difference between concentrations of individual 
sulfated polysaccharides (p < 0.05). 
 
2.6. Cell and Nuclear Morphology Change 
The 786 cells were exposed to SNFuc (0.5 mg/mL) for 24 h. Contrast microscopy showed that most 
cells became circular (Data not shown). Nuclear morphological changes were observed by DAPI 
staining. In the control group, 786 cells were rounded and homogeneously stained (Figure 7A). After 
24 h of treatment with SNFuc, blebbing nuclei, pycnotic bodies, morphological alterations and granular 
apoptotic bodies appeared (Figure 7B). Marked apoptotic morphologic alterations, including nuclear 
condensation, suggest nanoparticles induce apoptosis in 786 cells. 
Figure 7. Micrograph of 786 cells treated with SNFuc. These cells were incubated with  
0.5 mg/mL SNFuc for 24 h and labeled with DAPI to show nuclear morphology. (A) Control 
786 cells, without SNFuc; (B) 786 cells treated with SNFuc, showing nuclear morphological 
changes such as pyknosis (arrows). Bar, 10 µm. 
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2.7. Balance between Apoptosis and Necrosis 
In order to observe additional influences of SNFuc nanogel on 786 cell lines, apoptotic and necrotic 
status were analyzed. SNFuc (0.5 mg/mL) significantly (p < 0.001) increased the percentage of cells in 
early (from 2.5 to 14.0%) and late apoptosis (from 5.5 to 21.5%), whereas the percentage of necrotic 
cells was not significantly affected (Figure 8B).  
Figure 8. Changes in the percentage of normal, apoptotic and necrotic cells after  
SNFuc-TBA nanogel incubation. (A) Control; (B) Cells maintained in the presence of  
0.5 mg/mL SNFuc-TBA; (C) Cells kept in the presence of 0.5 mg/mL SNFuc and  
ZVAD-FMK; (D) Cells maintained in the presence of 0.5 mg/mL SNFuc and E-64. After 
24 h, cells were treated with Annexin V/PI and analyzed by Flow Cytometry. Q1: Annexin 
V negative/PI positive; Q2: Annexin V/PI positive; Q3: Annexin V positive/PI negative; 
Q4: Annexin V/PI negative. Analysis flow cytometry data was performed using FlowJo 
software v. 7.6.3. Similar results were obtained in three independent experiments. 
 
The most widely studied fucan with regard to its pro-apoptotic mechanism of action is the Fucus 
vesiculosus fucan, known as fucoidan. This fucan promotes caspase activation, inducing apoptosis of 
human lymphoma HS-sultan cells. However, when these cells were concomitantly incubated with 
fucoidan and a caspase inhibitor, the fucoidan effect was partially offset [29]. Thus, in order to 
determine the role of caspases in fucan A nanogel induced apoptosis, 786 cells were pre-incubated 
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with Z-VAD-FMK (pan-caspase inhibitor). This was followed by stimulation with 0.5 mg/mL SNFuc 
nanogel for 24 h and FACS analysis. Z-VAD-FMK modestly inhibited the fucan nanogel-induced late 
apoptosis to 14.3% (Figure 8C). Z-VAD-FMK did not completely inhibit the SNFuc nanogel effect. A 
synthetic inhibitor of cysteine proteinase (E-64) was also used, but did not alter the fucan nanogel 
effect on 786 cells (Figure 8D). 
In addition caspase-3 activation was examined in 786 cells, which were treated with or without 
SNFuc. Data in Figure 9 indicate that SNFuc promoted activation of caspase-3 in 786 cells. Several 
authors have shown fucan induces cell apoptosis by activated caspase-3 [29,30], as observed with 
SNFuc. However, the data from Figures 8 and 9 support the proposition that fucan nanogel induces 
apoptosis through both caspase and caspase-independent mechanisms.  
Figure 9. Effect of SNFuc (0.5 mg/mL) on caspase-3 activity in 786-0 cells after 24 h of 
treatment. p < 0.001 vs. negative control (untreated cells). 
 
Research conducted on fucans from brown seaweed give an indication of how pro-apoptotic fucans 
behave. In most cases, apoptosis induction is related to caspase activation. However, other proteins 
involved in cell survival pathways may be affected by the presence of SP in the culture medium. For 
example, the heterofucan from Undaria pinnatifida induced apoptosis in A549 human lung carcinoma 
cells through down-regulation of anti-apoptotic protein Bcl2 and activation of the caspase pathway. 
This heterofucan also down-regulated p38MAPK and PI3K/Akt and activated the ERK1/2MAPK 
pathway [31]. 
There are reports that caspase activation may not be necessary for apoptosis induction by some  
SPs. A recently published study showed a heterofucan with pro-apoptotic activity extracted from the 
seaweed Sargassum filipendula, denominated SF-1.5V. This SP inhibited HeLa (adenocarcinoma 
cervical cell) cell proliferation by apoptosis induction through a caspase-independent mechanism.  
SF-1.5v induces apoptosis in HeLa mainly by mitochondrial release of an apoptosis-inducing factor 
(AIF) into cytosol. In addition, SF-1.5v decreases the expression of Bcl-2 and increases expression of 
the apoptogenic protein Bax [14]. 
There are no data available regarding the antiproliferative mechanism of fucan nanogel. Further 
studies are therefore needed to clarify their mechanism, particularly with respect to SNFuc, which 
exhibited the strongest antiproliferative activity. 
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2.8. Cell Cycle Analysis 
The antiproliferative activity of fucans may also be a result of their interference in the cell cycle. 
Fucans from the seaweeds Turbinaria ornate [32] and Bifurcaria bifurcata inhibit proliferation of lung 
carcinoma (NSCLC-N6) by blocking its passage in the G1 phase of the cell cycle [33]. This effect was 
also observed with sulfated fucans from the seaweed Ascophyllum nodosum, which inhibit proliferation 
of NSCLC-N6 cell lines by blocking cell growth in the G1 phase [34]. As such, we also analyzed the 
effect of fucan nanogel on the 786 cell cycle. 
Analysis of the cell cycle after treatment of 786 cells with the SNFuc showed that, during incubation 
in the nanogel, the proportion of G0/G1 phase cells was reduced (Figure 10), and the percentage of 
cells at the S and G2/M phases of the cell cycle grew. This was accompanied by the appearance of a 
large number of apoptotic cells in the sub-G0/G1 phase. Data indicate that cells in the G1 phase during 
incubation entered the subsequent phase and stopped at this point. If cells entered apoptosis from the 
G1 phase, there was no accumulation of cells in S and G2/M phases.  
Figure 10. Evaluation of cell-cycle arrest after exposure to SNFuc. After 24 h of treatment 
with SNFuc (0.5 mg/mL), 786 cells were fixed, treated with RNase, stained with PI and 
analyzed by flow cytometry to assess cell cycle distribution. Control cells without SNFuc. 
Cell cycle arrest data were analyzed using FlowJo software v. 7.6.3. Similar results were 
obtained in three independent experiments. Different letters indicate a significant  
difference between concentrations of individual sulfated polysaccharides (a and b, p < 0.001; 
a′ and b′, p < 0.05). 
 
3. Experimental Section 
3.1. Materials 
Tetrabutylammonium fluoride trihydrate (TBA) and dimethyl sulfoxide (DMSO, H2O ≤ 0.005%), 
were obtained from Fluka (Buchs, Switzerland) and deuterium oxide (D2O) from Aldrich. Regenerated 
cellulose tubular membranes, with 12,000 MWCO, were obtained from Membrane Filtration Products 
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and hexadecylamine, 1-ethyl-3(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide 
(NHS) were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). Water used for synthesis and 
characterization was purified by distillation, deionization and reverse osmosis (Milli-Q Plus). All other 
chemicals and solvents were analytical grade and used as received. 
Fucan A from Spatoglossum schroederi was obtained as described by Almeida-Lima and  
colleagues [18] and its purity was determined by 
1
H RMN. 
3.2. Synthesis and Characterization of Fucan Conjugates 
To obtain nanogels from fucan using the methodology applied by Oudshoorn et al. [25], we initially 
dissolved the fucan using Tetrabutylammonium Fluoride Trihydrate (TBA) in order to activate the 
fucan carboxyl groups. Moreover, TBA was also chosen since any excess can be easily eliminated 
from the reaction medium by dialysis against a NaCl solution. This step is important because fucans 
are not soluble in DMSO, the solvent used to produce nanoparticles.  
To render fucans soluble in DMSO, the fucan linked sodium ions were exchanged with the lipophilic 
tetrabutylammonium (TBA) ion using ion exchange resin (Dowex
®
 50W-X8 cation exchange resin). 
The Fucan-TBA solution was lyophilized and used for chemical modification with hexadecylamine. 
Hydrophobic hexadecylamine was chemically conjugated to the backbone of Fucan-TBA in the 
presence of EDC and NHS. Briefly, Fucan-TBA was dissolved in DMSO and the reaction mixture was 
stirred for one day. Next, EDC, NHS and hexadecylamine were added and the reaction mixture was 
stirred for one day. The resulting solution was first dialyzed in a 150 mM sodium chloride solution for 
2 days, and then in dH2O for 3 days, in order to remove TBA and substitute it for the original Na
+
 ion. 
SNFuc derivative was obtained as a white powder (Figure 11). 
1
H NMR two-dimensional Correlation 
Spectroscoy analysis and elemental analysis was performed to analyze the structure of the reaction product. 
3.3. SNFuc Degree of Substitution 
The degree of substitution (DS) was estimated by the evaluation of N/S ratio as determined by 
elemental analysis, taking in account the fucan structure proposed in Figure 1. Considering the 
theoretical proportion of carboxylic to sulfate groups, DS is calculated based on the N/S ratio 
(proportional to the amide/sulfate ratio). 
3.4. Preparation of Self-Assembled Nanoparticles 
Lyophilized SNFuc was dissolved in ultra-pure water under stirring, at 50 °C, until a clear solution 
was obtained. In the range of SNFuc used to prepare a 1 g/dL solution, 3 h of stirring is the maximum 
time required to dissolve SNFuc. The solution of self-assembled nanoparticles was then filtered 
through a 0.45 µm filter and stored at room temperature. 
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Figure 11. Synthetic scheme of fucan A nanogel synthesis. TBA: Tetrabutylammonium 
Fluoride Trihydrate; EDC: 1-ethyl-3(3-dimethylaminopropyl) carbodiimide; NHS:  
N-hydroxysuccinimide; R1, R2 and R3: side chain of fucan A (see Figure 1). 
 
3.5. Size Distribution, Zeta Potential and CryoSEM Observation 
Size distribution, zeta potential and nanoparticle volume were determined with a Malvern Zetasizer, 
NANO ZS (Malvern Instruments Limited, UK), using an He-Ne laser (wavelength of 633 nm) and 
detector angle of 173°. Size distribution and zeta potential were established through dynamic light 
scattering (DLS). 
For size distribution measurements, a dispersion of nanoparticles in ultra-pure water (1 mL) was 
analyzed at 25 °C in a polystyrene cell. Nanoparticle concentration was adjusted by dilution with 
ultrapure water with concentrated nanoparticle dispersion. 
The fucan nanogel concentrated by ultrafiltration (Amicon Ultra-4 Centrifugal Filter Units,  
cutoff molecular weight 1 × 10
5
) was negatively stained with phosphotungstic acid (Riedel-de Haën;  
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0.01% w/v) and observed by Cryo-scanning electron microscopy (cryoSEM), using an electronic 
microscope (SEM/EDS: FESEM JEOL JSM6301F/Oxford Inca Energy 350). 
DLS cumulant analysis characterizes samples using the mean value (z-average) for size and a width 
parameter known as polydispersity, or the polydispersity index (PdI). The z-average diameter is the 
mean hydrodynamic diameter, determined by the intensity of scattered light. Fundamental size 
distribution generated by DLS is an intensity distribution, which can be converted to volume 
distribution using Mie theory. Volume distribution can in turn be further converted to a number 
distribution. The present study considers the z-average as the best approach for actual nanoparticles 
size. Each sample was analyzed in a folded capillary cell. Zeta potential values were calculated using 
the Smoluchowski equation. Repeated measurements were performed (3 times) and values reported are 
average values. 
3.6. 
1
H NMR and Elemental Analysis  
Lyophilized reaction products were dispersed in D2O (10 mg/mL), as were nanoparticles and fucan 
(10 mg/mL). Samples were stirred overnight at 50 °C to obtain a clear dispersion, which was transferred 
to 5 mm NMR tubes. One-dimensional 
1
H NMR and two-dimensional correlation spectroscopy (COSY) 
measurements were performed with a Varian Unity Plus 300 spectrometer operating at 299.94 MHz.  
Elemental analysis was performed using a Leco CHNS 932. The sample was lyophilized and 
analyzed in the solid state. 
3.7. Antiproliferative Activity 
The present study used monocyte macrophage (RAW 264) cells, Chinese hamster ovary (CHO) 
cells, renal cell carcinoma (786-0) cells, hepatocellular carcinoma (HepG2) cells, and aorta endothelial 
cells (RAEC). Cells were grown in F-12 (RAEC) or DMEM (all others) medium supplemented with 
10% newborn calf serum (Cutilab, Campinas-SP, Brazil) and penicillin-streptomycin (1 mg/mL; 
Sigma-Aldrich, St Louis, MO, USA), and incubated at 37 °C in 5% CO2. Cell viability was assessed 
using trypan blue (Sigma). 
Cell cultures were grown in 75 cm
2
 flasks in DMEM medium. Cells were seeded into 96-well plates 
at a density of 5 × 10
3
 cells/well and allowed to attach overnight in 300 µL medium incubated at  
37 °C, 5% CO2. The fucan nanogel was added at a final concentration of 0.05/0.1 and 0.5 mg/mL for 
24 h, at 37 °C and 5% CO2. After incubation, traces of nanogel were removed by washing the cells 
twice with 200 µL PBS and applying 100 µL of fresh medium and 10 µL of 12 mM MTT dissolved in 
PBS to determine the effects of the fucan nanogel on cell proliferation. Cells were then incubated for  
4 h at 37 °C and 5% CO2. To solubilize the product of MTT cleavage, 100 µL of isopropanol 
containing 0.04 N HCl was added to each well and thoroughly mixed using a multichannel pipette. 
Within 1 h of HCl-isopropanol addition, absorbance at 570 nm was read using a Multiskan Ascent 
Microplate Reader (Thermo Labsystems, Franklin, MA, USA). The percentage of cell proliferation 
inhibition was calculated as follows: 
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In addition the tumor cells proliferation in the presence of SNFuc was also determined after 4 h of 
BrdU incorporation. Cells were seeded into 96-well plates at a density of 5 × 10
3
 cells/well and 
allowed to attach overnight in 300 µL medium incubated at 37 °C, 5% CO2. The fucan nanogel was 
added at a final concentration of 0.5 mg/mL for 24 h, at 37 °C and 5% CO2. After incubation, traces of 
nanogel were removed by washing the cells twice with 200 µL PBS and the BrdU incorporation was 
determined accordance with the manufacturer’s instruction (BrdU cell proliferation assay kit, Cell 
Signaling, Danvers, MA, USA). 
3.8. Fourier Transformed Infrared Spectroscopy (FT-IR) 
The compound (Fucan A and SNFuc) (20 mg) were mixed thoroughly with dry potassium bromide. 
A pellet was prepared and the infrared spectrum was measured on a Thermo Nicolet spectrometer 
instrument, model Nexus 470 FT-IR, between 500 and 4000 cm
−1
. Thirty-two scans at a resolution of  
4 cm
−1
 were averaged and referenced against air [35].  
3.9. Annexin V-FITC/PI Double Staining and Analysis by Flow Citometry 
In order to evaluate the effects of SNFuc on cell death, a FITC/Annexin V Apoptosis Kit was used, 
with Dead Cell Annexin FITC and PI, for Flow Cytometry (Invitrogen, Catalog no. V13242). Cells 
were grown in 6-well plates until they reached confluence of 2 × 10
5
 cells/mL and were then stimulated 
to enter G0 in a medium without serum for 48 h. Next, cells were to exit G0 by adding DMEM 
supplemented with 10% FBS, in the presence of SNFuc (0.5 mg/mL) or not. A negative control was 
prepared without the presence of SNFuc, and the action of SNFuc incubated with pan-caspase inhibitor 
Z-VAD-FMK (carbobenzóxy valyl-alanyl-aspartyl-[O-methyl]-fluorometilcetone) was also tested 
(0.02 mM). After 24 h, 786 cells were trypsinized, collected and washed with cold PBS. The 
supernatant was discarded and cells were resuspended in 200 µL of 1× Binding Buffer. Five microlitres 
of Annexin V-FITC and 1 µL of PI solution 100 µg/mL was added in 100 µL of cell suspension. Cells 
were incubated for 15 min at room temperature and kept under light protection. After the incubation 
period, 400 µL of binding buffer for annexin V 1× was added and cells were analyzed by flow 
cytometry (flow cytometer FASCANTO II, BD Biosciences), measuring fluorescence emission at 
530–575 nm for annexin V and 630/22 nm for PI. FlowJo software v. 7.6.3 (Tree Star, Inc., CA, USA) 
was used for data analysis as described in Rabelo and colleagues [36]. 
3.10. Cell Cycle Analysis 
786 cells were washed with cold PBS and the supernatant was discarded. The pellet of cells was 
then incubated with 2% paraformaldehyde, washed with cold PBS and permeabilized with  
0.01% saponin for 15 min. After this procedure, cells were incubated with 10 µL of RNase (4 mg/mL) 
at 37 °C for 30 min. Five microlitres of PI solution (25 mg/mL) and 200 µL of cold PBS were added 
and cells were transferred to a flow cytometer for analysis of cell cycle arrest (630/22 nm). The 
percentage of apoptotic cells was determined every 20,000 events and graphs obtained in the 
experiment represent data from three independent experiments. FlowJo software v. 7.6.3 (Tree Star, 
Inc., CA, USA) was used for data analysis [36]. 
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3.11. Caspase-3 Activity Assay 
786-0 cells were placed in a petri dishes (1 × 10
6
 cells/mL), and after 24 h of incubation, cells were 
incubated with SNFuc and washed after 24 h in ice-cold PBS and scraped into 200 mL lysis buffer  
[50 mM Tris-HCl (pH 7.4), 1% Tween 20, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 
1 mM Na3VO4, 1 mM NaF], and protease inhibitors [1 mg/mL aprotinin, 10 mg/mL leupeptin and  
1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride] for 2 h 4 °C. The same conditions were used for 
untreated cells. Protein extracts were cleared by centrifugation and protein concentrations were 
determined using Bradford reagent with bovine serum albumin as standard. In vitro caspase-3 protease 
activity was measured using a caspase activation kit according to the manufacturer’s protocol 
(Invitrogen, Carlsbad, CA, USA). 50 µL of cell lysate (200 µg of protein) was mixed with 50 µL of  
2× reaction buffer [containing 10 µL of 1 M dithiothreitol and 5 µL of 4 mM synthetic tetrapeptide  
Asp-Glue-Val-Asp conjugated top-nitroanilide (pNA)] in 96-well plate, after which the mixture was 
incubated for 2 h at 37 °C in the dark. Active caspase cleaves the peptide and releases the chromophore 
pNA that can be detected at 405 nm. Theoretically, the apoptotic cell lysates containing active tested 
caspases should yield a considerable emission compared with the non-apoptotic cell lysates. Data presented 
are representative of those obtained in at least three independent experiments done in duplicates. 
3.12. Statistical Analysis 
Mean and standard-error of the mean (SEM) were calculated for all quantitative data. For 
antiproliferative assays, data were analyzed by one-way analysis of variance (ANOVA). When 
signiﬁcant intergroup differences occurred, these were assessed by Student-Newmans-Keuls post-tests 
for multiple group comparison. In all cases, statistical signiﬁcance was set at p < 0.05 or <0.001. 
4. Conclusions 
The present study prepared and characterized a nanogel, formed by an inner hydrophobic core 
(represented by hexadecylamine), surrounded by hydrophilic chains (represented by sulfated fucan). 
The resulting fucan nanogel exhibited a robust structure in aqueous solution, which was stable for 
several weeks. Fucan nanogel inhibits 786, RAEC, H-S5 and HepG2 cell proliferation. In addition,  
this nanogel induces 786 cell deaths by inducing apoptosis through dependent and independent 
mechanisms of caspases activation and by blocking 786 cell passages in the S and G2/M phases of the 
cell cycle. Since the fucan nanogel demonstrated an antiproliferative effect against tumor cells, its use, 
in conjunction with anti-tumor drugs either transported by nanogel or not, shows significant potential 
in the treatment of different cancers. 
Acknowledgements 
The present study was supported by CAPES, MCT, FAPERN/CNPq and CNPq, Brazil, as well as 
FCT, Portugal. N Dantas-Santos, J Almeida-Lima, AAJ Vidal, HAO Rocha are grateful to the CNPq 
and CAPES for their fellowship support. This research was submitted to the Graduate Program in 
Health Sciences at the Federal University of Rio Grande do Norte as part of the D.Sc. thesis of ND-S. 
  
Mar. Drugs 2012, 10 2020 
 
 
References 
1. Kabanov, A.V.; Vinogradov, S.V. Nanogels as pharmaceutical carriers: Finite networks of infinite 
capabilities. Angew. Chem. Int. Ed. Engl. 2009, 48, 5418–5429. 
2. Stolnik, S.; Illum, L.; Davis, S.S. Long circulating microparticulate drug carriers. Adv. Drug 
Deliv. Rev. 1995, 16, 195–214. 
3. Norman, M.E.; Williams, P.; Illum, L. Human serum-albumin as a probe for surface conditioning 
(opsonization) of block copolymer-coated microspheres. Biomaterials 1992, 13, 841–849. 
4. Esmaeili, F.; Ghahremani, M.H.; Esmaeili, B.; Khoshayand, M.R.; Atyabi, F.; Dinarvand, R. 
PLGA nanoparticles of different surface properties: Preparation and evaluation of their body 
distribution. Int. J. Pharm. 2008, 349, 249–255. 
5. Liu, Z.; Chen, K.; Davis, C.; Sherlock, S.; Cao, Q.; Chen, X.; Dai, H. Drug delivery with carbon 
nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68, 6652–6660. 
6. Lemarchand, C.; Gref, R.; Passirani, C.; Garcion, E.; Petri, B.; Muller, R.; Costantini, D.; 
Couvreur, P. Influence of polysaccharide coating on the interactions of nanoparticles with 
biological systems. Biomaterials 2006, 27, 108–118. 
7. Gonçalves, C.; Torrado, E.; Martins, T.; Pereira, P.; Pedrosa, J.; Gama, M. Dextrin nanoparticles: 
Studies on the interaction with murine macrophages and blood clearance. Colloids Surf. B 
Biointerfaces 2010, 75, 483–489. 
8. Liu, C.G.; Chen, X.G.; Park, H.J. Self-assembled nanoparticles based on linoleic-acid 
modifiedchitosan: Stability and adsorption of trypsin. Carbohydr. Polym. 2005, 62, 293–298.  
9. Bae, K.H.; Mok, H.; Park, T.G. Synthesis, characterization, and intracellular delivery of reducible 
heparin nanogels for apoptotic cell death. Biomaterials 2008, 29, 3376–3383. 
10. Nader, H.B.; Lopes, C.C.; Rocha, H.A.O.; Santos, E.A.; Dietrich, C.P. Heparins and heparinoids: 
Occurrence, structure and mechanism of antithrombotic and hemorrhagic activities. Curr. Pharm. 
Des. 2004, 10, 951–966. 
11. Lima, M.A.; Rudd, T.R.; de Farias, E.H.; Ebner, L.F.; Gesteira, T.F.; de Souza, L.M.; Mendes, A.; 
Córdula, C.R.; Martins, J.R.; Hoppensteadt, D.; et al. A new approach for heparin standardization: 
Combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component 
analysis. PLoS One 2011, 6, e15970. 
12. Lira, M.C.B.; Santos-Magalhães, N.S.; Nicolas, V.; Marsaud, V.; Silva, M.P.C.; Ponchel, G.; 
Vauthier, C. Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles. 
Eur. J. Pharm. Biopharm. 2011, 79, 162–170. 
13. Pomin, V.H. Structural and functional insights into sulfated galactans: A systematic review. 
Glycoconj. J. 2010, 27, 1–12. 
14. Costa, L.S.; Fidelis, G.P.; Telles, C.B.; Dantas-Santos, N.; Camara, R.B.; Cordeiro, S.L.;  
Pereira-Costa, M.S.; Almeida-Lima, J.; Melo-Silveira, R.F.; Oliveira, R.M.; et al. Antioxidant and 
antiproliferative activities of heterofucans from the seaweed Sargassum filipendula. Mar. Drugs 
2011, 9, 952–966. 
15. Ale, M.T.; Mikkelsen, J.D.; Meyer, A.S. Important determinants for fucoidan bioactivity: A 
critical review of structure-function relations and extraction methods for fucose-containing 
sulfated polysaccharides from brown seaweeds. Mar. Drugs 2011, 9, 2106–2130. 
Mar. Drugs 2012, 10 2021 
 
 
16. Leite, E.L.; Medeiros, M.G.L; Rocha, H.A.O.; Farias, G.G.M.; Silva, L.F.; Chavante, S.F.;  
Abreu, L.R.D.; Dietrich, C.P.; Nader, H.B. Structure and pharmacological activities of a sulfated 
xylofucoglucuronan from the alga Spatoglossum schröederi. Plant Sci. 1998, 132, 215–228. 
17. Almeida-Lima, J.; Costa, L.S.; Silva, N.B.; Melo-Silveira, R.F.; Silva, F.V.; Felipe, M.B.M.C.; 
Medeiros, S.R.B.M.; Leite, E.L.; Rocha, H.A.O. Evaluating the possible genotoxic, mutagenic 
and tumor cell proliferation-inhibition effects of a non-anticoagulant, but antithrombotic algal 
heterofucan. J. Appl. Toxicol. 2010, 30, 708–715. 
18. Almeida-Lima, J.; Dantas-Santos, N.; Gomes, D.L.; Cordeiro, S.L.; Sabry, D.A.; Costa, L.S.; 
Freitas, M.L.; Silva, N.B.; Moura, C.E.B.; Lemos, T.M.A.M.; et al. Evaluation of acute and 
subchronic toxicity of a non-anticoagulant, but antithrombotic algal heterofucan from the 
Spatoglossum schröederi in Wistar rats. Rev. Bras. Farmacogn. 2011, 21, 674–679. 
19. Barroso, E.M.; Costa, L.S.; Medeiros, V.P.; Cordeiro, S.L.; Costa, M.S.P.; Franco, C.R.; Nader, H.B.; 
Leite, E.L.; Rocha, H.A.O. A non-anticoagulant heterofucan has antithrombotic activity in vivo. 
Planta Med. 2008, 74, 712–708. 
20. Wang, X.; Wang, J.; Zhang, J.; Zhao, B.; Yao, J.; Wang, Y. Structure-antioxidant relashionships 
of sulfated galactomannan from guar gum. Int. J. Biol. Macromol. 2010, 46, 59–66. 
21. Shumbula, P.M.; Moloto, M.J.; Tshikhundo, T.R.; Fernandes, M. Dichloro(bis[diphenylthiourea]) 
cadmium complex as a precursor for HDA-capped CdS nanoparticles and their solubility in water. 
S. Afr. J. Sci. 2010, 106, 1–7. 
22. Xu, X.; Li, S.; Jia, F.; Liu, P. Synthesis and antimicrobial activity of nano-fumed sílica derivative 
with N,N-dimethyl-n-hexadecylamine. Life Sci. J. 2006, 3, 59–62. 
23. Camara, R.B.G.; Costa, L.S.; Fidelis, G.P.; Nobre, L.T.D.B.; Dantas-Santos, N.; Cordeiro, S.L.; 
Costa, M.S.S.P.; Alves, L.G.; Rocha, H.A.O. Heterofucans from the Brown Seaweed  
Canistrocarpus cervicornis with anticoagulant and antioxidant activities. Mar. Drugs 2011, 9, 
124–138. 
24. Kong, J.; Yu, S. Fourier transform infrared spectroscopic analysis of protein secondary structures. 
Acta Biochim. Biophys. Sin. 2007, 38, 549–559. 
25. Oudshoorn, M.H.M.; Rissmann, R.; Bouwstra, J.A.; Hennink, W.E. Synthesis of methacrylated 
hyaluronic acid with tailored degree of substitution. Polymer 2007, 48, 1915–1920. 
26. Ferreira, S.A.; Coutinho, P.J.G.; Gama, F.M. Self-Assembled nanogel made of mannan: Synthesis 
and characterization. Langmuir 2010, 26, 11413–11420. 
27. Goncalves, C.; Martins, J.A.; Gama, F.M. Self-Assembled nanoparticles of dextrin substituted 
with Hexadecanethiol. Biomacromolecules 2007, 8, 392–398. 
28. Fichthorn, K.A.; Qin, Y. Molecular dynamics simulation of colloidal nanoparticle forces.  
Ind. Eng. Chem. Res. 2006, 45, 5477–5481. 
29. Aisa, Y.; Miyakawa, Y.; Nakazato, T.; Shibata, H.; Saito, K.; Ikeda, Y.; Kizaki, M. Fucoidan 
induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and  
down-regulation of ERK pathways. Am. J. Hematol. 2005, 78, 7–14.  
30. Ale, M.T.; Maruyama, H.; Tamauchi, H.; Mikkelsen, J.D.; Meyer, A.S. Fucose-Containing 
sulfated polysaccharides from brown seaweeds inhibit proliferation of melanoma cells and induce 
apoptosis by activation of caspase-3 in vitro. Mar. Drugs 2011, 9, 2605–2621. 
Mar. Drugs 2012, 10 2022 
 
 
31. Boo, H.; Hyun, J.; Kim, S.; Kang, J.; Kim, M.; Kim, S.; Cho, H.; Yoo, E.; Kang, H. Fucoidan 
from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells. Phytother. Res. 
2011, 25, 1082–1086. 
32. Deslandes, E.; Pondaven, P.; Auperin, T.; Roussakis, C.; Guézennec, J.; Stiger, V.; Payri, C. 
Preliminary study of the in vitro antiproliferative effect of a hydroethanolic extract from  
the subtropical seaweed Turbinaria ornata (Turner) J. Agardh on a human non small cell 
bronchopulmonary carcinoma line (NSCLC-N6). J. Appl. Phycol. 2000, 12, 257–262. 
33. Moreau, D.; Thomas-Guyon, H.; Jacquot, C.; Jugé, M.; Culioli, G.; Ortalo-Magné, A.; Piovetti, L.; 
Roussakis, C. An extract from the brown alga Bifurcaria bifurcata induces irreversible arrest of 
cell proliferation in a non-small-cell bronchopulmonary carcinoma line. J. Appl. Phycol. 2006, 18, 
87–93. 
34. Riou, D.; Coliec-Jouault, S.; Sel, D.P.; Bosch, S.; Siavoshian, S.; Bert, V.; Tomasoni, C.; Sinsuin, C.; 
Durand, P.; Roussakis, C. Antitumor and antiproliferative effects of a fucan extracted from 
Ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer 
Res. 1996, 16, 1213–1218. 
35. Silva, F.R.F.; Dore, C.M.P.G.; Marques, C.T.; Nascimento, M.S.; Benevides, N.M.B.; Rocha, H.A.O.; 
Chavante, S.F.; Leite, E.L. Anticoagulant activity, paw edema and pleurisy induced carrageenan: 
Action of major types of commercial carrageenans. Carbohydr. Polym. 2010, 79, 26–33. 
36. Rabelo, L.; Monteiro, N.; Serquiz, R.; Santos, P.; Oliveira, R.; Oliveira, A.; Rocha, H.; Morais, A.H.; 
Uchoa, A.; Santos, E. A lactose-binding lectin from the marine sponge Cinachyrella apion (Cal) 
induces cell death in human cervical adenocarcinoma cells. Mar. Drugs 2012, 10, 727–743. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
